Literature DB >> 11175900

Structure of free BglII reveals an unprecedented scissor-like motion for opening an endonuclease.

C M Lukacs1, R Kucera, I Schildkraut, A K Aggarwal.   

Abstract

Restriction endonuclease BglII completely encircles its target DNA, making contacts to both the major and minor grooves. To allow the DNA to enter and leave the binding cleft, the enzyme dimer has to rearrange. To understand how this occurs, we have solved the structure of the free enzyme at 2.3 A resolution, as a complement to our earlier work on the BglII-DNA complex. Unexpectedly, the enzyme opens by a dramatic 'scissor-like' motion, accompanied by a complete rearrangement of the alpha-helices at the dimer interface. Moreover, within each monomer, a set of residues--a 'lever'--lowers or raises to alternately sequester or expose the active site residues. Such an extreme difference in free versus complexed structures has not been reported for other restriction endonucleases. This elegant mechanism for capturing DNA may extend to other enzymes that encircle DNA.

Mesh:

Substances:

Year:  2001        PMID: 11175900     DOI: 10.1038/84111

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  4 in total

1.  Protein stability indicates divergent evolution of PD-(D/E)XK type II restriction endonucleases.

Authors:  Monika Fuxreiter; István Simon
Journal:  Protein Sci       Date:  2002-08       Impact factor: 6.725

2.  2'-O-methyl nucleotide modified DNA substrates influence the cleavage efficiencies of BamHI and BglII.

Authors:  Zhaoxue Tong; Bin Zhao; Guojie Zhao; Hong Shang; Yifu Guan
Journal:  J Biosci       Date:  2014-09       Impact factor: 1.826

Review 3.  Structure and function of type II restriction endonucleases.

Authors:  A Pingoud; A Jeltsch
Journal:  Nucleic Acids Res       Date:  2001-09-15       Impact factor: 16.971

4.  Photochemical regulation of restriction endonuclease activity.

Authors:  Douglas D Young; Jeane M Govan; Mark O Lively; Alexander Deiters
Journal:  Chembiochem       Date:  2009-07-06       Impact factor: 3.164

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.